Welcome to OSdream !


Tumor metastasis and recurrence are urgent clinical problems in tumor treatment. Recurrence-free survival (RFS), Metastasis-free survival (MFS) and differentially expressed genes (DEGs) analyses may enable finding and validating effective markers to predict prognosis and the occurrence of metastasis and recurrence. OSdream, including 144 datasets of 33 tumor types from TCGA, GEO databases and literatures, is established to explore RFS and MFS for gene of interest in one certain tumor. Moreover, the online tool could also perform differentially expressed genes (DEGs) analysis between patients with recurrence and without recurrence, between patients with metastasis and without metastasis, between primary tumor and its metastasis.

Number of samples:

MFS analysis: 3505

RFS analysis: 12722

DEGs analysis of metastasis: 6043

DEGs analysis of recurrence: 13371

Total samples number:22919

Tumor abbreviations:

BLCA Bladder Urothelial Carcinoma

BRCA Breast invasive carcinoma

COAD Colon adenocarcinoma

ESCA Esophageal carcinoma

full list

Please Cite OSdream in your works: Huimin Li, Qiang Wang, Yunyi Liu, Lin Chen, Qiwei Zhao, Longxiang Xie, Lu Zhang, Zhongyi Yan, Guosen Zhang, Yali Han, Wan Zhu, Xiangqian Guo, OSdream: An online survival and differential analysis tool of recurrence and metastasis of pan-cancers, Genes & Diseases, 2024, 101446, ISSN 2352-3042, https://doi.org/10.1016/j.gendis.2024.101446.

Copyright © 2021 Biomedical Informatics Institute